Acrotech Biopharma Discontinued
FDA Approved Drugs

Acrotech Biopharma Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 4
  • Latest Approval Date Oct 19, 2018
  • Data Source FDA
  • First Approval Date Mar 07, 2008
All
10
View
Discontinued
4
View
RX
6
View
Company Overview

Company

Acrotech Biopharma Discontinued

Country

U.S.A

Website

Visit Website

Email

info@AcrotechBiopharma.com

Social Profiles

LinkedIn
Company Snapshot

Acrotech Biopharma Discontinued

279 Princeton Hightstown Rd., East Windsor, NJ 08520 (866) 850-2876

U.S.A

acrotechbiopharma.com/ info@AcrotechBiopharma.com View on Map
FDA Approved Drug Records ( 4 records )
2008
07 Mar
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2008-03-07

20140 / 1

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

1

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

Approval Date

2008-03-07

Regulatory Status

Discontinued

2011
29 Apr
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

2

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

20140 / 2

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

2

Dosage Form

-

Strength

EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

Regulatory Status

Discontinued

2011
29 Apr
Discontinued Application: 20140

Drug Name

FUSILEV

Product Number

3

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

20140 / 3

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Application Number

20140

Product Number

3

Dosage Form

-

Strength

EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2011-04-29

Regulatory Status

Discontinued

2018
19 Oct
Discontinued Application: 211226

Drug Name

KHAPZORY

Product Number

2

Dosage Form

-

Strength

300MG/VIAL

Approval Date

2018-10-19

211226 / 2

Active Ingredient

LEVOLEUCOVORIN

Application Number

211226

Product Number

2

Dosage Form

-

Strength

300MG/VIAL

Approval Date

2018-10-19

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    10 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
4 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

FUSILEV

Application Number

20140

Product Number

1

Active Ingredient

LEVOLEUCOVORIN CALCIUM

Dosage Form

-

Strength

EQ 50MG BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit